Get the Stockscreener App
6.13
3.55%
0.21
After Hours:
6.13
Aura Biosciences Inc stock is traded at $6.13, with a volume of 335.93K.
It is up +3.55% in the last 24 hours and down -0.81% over the past month.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
See More
Previous Close:
$5.92
Open:
$5.96
24h Volume:
335.93K
Relative Volume:
1.67
Market Cap:
$380.79M
Revenue:
-
Net Income/Loss:
$-76.41M
P/E Ratio:
-3.1927
EPS:
-1.92
Net Cash Flow:
$-64.56M
1W Performance:
+3.55%
1M Performance:
-0.81%
6M Performance:
+15.66%
1Y Performance:
-32.49%
1-Day Range:
$5.80
$6.25
1-Week Range:
$5.72
$6.25
52-Week Range:
$4.345
$12.38
Aura Biosciences Inc Stock (AURA) Company Profile
Name
Aura Biosciences Inc
Sector
Industry
Phone
(617)500-8864
Address
80 GUEST STREET, BOSTON
Compare AURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
6.13 | 367.75M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Resumed | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | H.C. Wainwright | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Apr-17-23 | Resumed | BTIG Research | Buy |
| Jul-19-22 | Initiated | JMP Securities | Mkt Outperform |
Aura Biosciences Inc Stock (AURA) Latest News
How analysts rate Aura Biosciences Inc. stock today2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - newser.com
What recovery options are there for Aura Biosciences Inc.Weekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Pattern recognition hints at Aura Biosciences Inc. upside2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
How to build a dashboard for Aura Biosciences Inc. stockWall Street Watch & Community Verified Swing Trade Signals - newser.com
How to read the order book for Aura Biosciences Inc.July 2025 Earnings & Technical Buy Zone Confirmations - newser.com
Real time pattern detection on Aura Biosciences Inc. stockStop Loss & Momentum Based Trading Signals - newser.com
Combining machine learning predictions for Aura Biosciences Inc.2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
Evaluating Aura Biosciences Inc. with trendline analysisTrade Risk Summary & Weekly Top Gainers Trade List - newser.com
Is Aura Biosciences Inc. stock cheap compared to fundamentalsEarnings Summary Report & Accurate Entry/Exit Alerts - newser.com
Using portfolio simulators with Aura Biosciences Inc. includedMarket Performance Summary & Fast Entry High Yield Stock Tips - newser.com
How Aura Biosciences Inc. stock reacts to global recession fears2025 Market Overview & Accurate Buy Signal Alerts - newser.com
Moderate to Severe Atopic Dermatitis Pipeline Drugs Insights Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight - The Globe and Mail
What high frequency data says about Aura Biosciences Inc.2025 Historical Comparison & Verified Short-Term Plans - newser.com
Is Aura Biosciences Inc. trending in predictive chart modelsQuarterly Portfolio Report & Daily Volume Surge Signals - newser.com
Aura Biosciences Inc. recovery potential after sell offProfit Target & AI Based Trade Execution Alerts - newser.com
News impact scoring models applied to Aura Biosciences Inc.Weekly Trade Recap & Accurate Trade Setup Notifications - newser.com
Can Arunjyothi Bio Ventures Limited Compete Globally or Is It a Local Player OnlyMonthly Performance Summary & Fast Profit Strategies - earlytimes.in
How sentiment analysis helps forecast Aura Biosciences Inc.July 2025 Closing Moves & High Return Stock Watch Alerts - newser.com
Is Aura Biosciences Inc. stock attractive for hedge funds2025 Macro Impact & Verified Momentum Stock Ideas - newser.com
Using AI based signals to follow Aura Biosciences Inc.Earnings Recap Report & Real-Time Volume Triggers - newser.com
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Is Aura Biosciences Inc. stock recession proofJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - newser.com
Is Aura Biosciences Inc. showing signs of accumulation2025 Key Lessons & Real-Time Buy Zone Alerts - newser.com
Non Muscle Invasive Bladder Cancer Pipeline 2025: Pioneering - openPR.com
Aura Biosciences Inc Stock (AURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aura Biosciences Inc Stock (AURA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Elazzouzi Amy | Senior Vice President, Finance |
Aug 18 '25 |
Sale |
6.70 |
7,722 |
51,737 |
86,558 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):